We are an early-stage biotechnology company based in La Jolla, California.  Our focus is on the promising and rapidly developing field of personalized medicine.  We carry out R&D in the area of novel assays and biomarker discovery, and use next-generation sequencing technologies for the analysis of complex systems.  We enable others to make use of our genomics and technology expertise by providing next-generation sequencing services through Sequensys, a division of the company.

MANAGEMENT

MARK CHEE, PH.D.

President and CEO

Dr. Chee is internationally recognized as a leader in the field of genomics.  He co-founded Illumina, Inc., where he was VP of Genomics and Bioinformatics.  Prior to that he was Director of Genetics Research at Affymetrix, Inc.  Dr. Chee has published ~40 scientific papers and is an inventor on over 50 issued U.S. patents.  Dr. Chee is an advisor to the National Institutes of Health, serving on the National Advisory Council for Human Genome Research and the External Scientific Committee of The Cancer Genome Atlas project.  He also serves on the Scientific Advisory Boards of Complete Genomics and febit.